Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1973 Oct 6;109(7):585–587.

Resistance of Pseudomonas aeruginosa to gentamicin

P Chadwick
PMCID: PMC1946942  PMID: 4200481

Abstract

The resistance to gentamicin 4 μg./ml. of 250 Pseudomonas aeruginosa isolates was measured by a proportion method. Twenty-eight (11.2%) of the cultures fell into the most resistant group, in whose populations between 10 and 100% of the organisms were resistant. A relatively high percentage of urinary isolates and a comparatively low percentage of isolates from respiratory sources occurred in this group. Three of the 28 were resistant to carbenicillin 150 μg./ml. and 6 of 18 tested were as resistant to gentamicin 8 μg./ml. as they were to 4 μg./ml. The distribution of Ps. aeruginosa isolates between the different grades of resistance did not change significantly during the 10 months in which the survey was performed.

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYLIFFE G. A., LOWBURY E. J., HAMILTON J. G., SMALL J. M., ASHESHOV E. A., PARKER M. T. HOSPITAL INFECTION WITH PSEUDOMONAS AERUGINOSA IN NEUROSURGERY. Lancet. 1965 Aug 21;2(7408):365–368. doi: 10.1016/s0140-6736(65)90343-0. [DOI] [PubMed] [Google Scholar]
  2. Bell S. M., Smith D. D. Resistance of Pseudomonas aeruginosa to carbenicillin. Lancet. 1969 Apr 12;1(7598):753–754. doi: 10.1016/s0140-6736(69)91754-1. [DOI] [PubMed] [Google Scholar]
  3. Bergfors S., Burman L. G., Eklöf P. H., Nordström K., Tärnvik A. Transferable and non-transferable drug resistance in enteric bacteria isolated from urinary specimens in Northern Sweden. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(4):511–518. doi: 10.1111/j.1699-0463.1972.tb00174.x. [DOI] [PubMed] [Google Scholar]
  4. Chadwick P. An approach to quantitative antibiotic sensitivity testing for some gram-negative pathogens. Can J Microbiol. 1972 Jul;18(7):1145–1151. doi: 10.1139/m72-176. [DOI] [PubMed] [Google Scholar]
  5. Darrell J. H., Waterworth P. M. Dosage of gentamicin for pseudomonas infections. Br Med J. 1967 May 27;2(5551):535–537. doi: 10.1136/bmj.2.5551.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dexter F. Pseudomonas aeruginosa in a regional burns centre. J Hyg (Lond) 1971 Jun;69(2):179–186. doi: 10.1017/s0022172400021410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fierer J., Taylor P. M., Gezon H. M. Pseudomonas aeruginosa epidemic traced to delivery-room resuscitators. N Engl J Med. 1967 May 4;276(18):991–996. doi: 10.1056/NEJM196705042761801. [DOI] [PubMed] [Google Scholar]
  8. Gardner P., Smith D. H. Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med. 1969 Jul;71(1):1–9. doi: 10.7326/0003-4819-71-1-1. [DOI] [PubMed] [Google Scholar]
  9. Gingell J. C., Waterworth P. M. Dose of gentamicin in patients with normal renal function and renal impairment. Br Med J. 1968 Apr 6;2(5596):19–22. doi: 10.1136/bmj.2.5596.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hinshaw V., Punch J., Allison M. J., Dalton H. P. Frequency of R factor-mediated multiple drug resistance in Klebsiella and Aerobacter. Appl Microbiol. 1969 Feb;17(2):214–218. doi: 10.1128/am.17.2.214-218.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KLEIN J. O., EICKHOFF T. C., FINLAND M. GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS. Am J Med Sci. 1964 Nov;248:528–544. [PubMed] [Google Scholar]
  12. Klastersky J., Swings G., Daneau D. Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli. Am J Med Sci. 1970 Dec;260(6):373–380. doi: 10.1097/00000441-197012000-00006. [DOI] [PubMed] [Google Scholar]
  13. Lowbury E. J., Lilly H. A., Kidson A., Ayliffe G. A., Jones R. J. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet. 1969 Aug 30;2(7618):448–452. doi: 10.1016/s0140-6736(69)90163-9. [DOI] [PubMed] [Google Scholar]
  14. Lowbury E. J., Thom B. T., Lilly H. A., Babb J. R., Whittall K. Sources of infection with Pseudomonas aeruginosa in patients with tracheostomy. J Med Microbiol. 1970 Feb;3(1):39–56. doi: 10.1099/00222615-3-1-39. [DOI] [PubMed] [Google Scholar]
  15. Meyer R. D., Young L. S., Armstrong D. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol. 1971 Dec;22(6):1147–1151. doi: 10.1128/am.22.6.1147-1151.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sykes R. B., Richmond M. H. Intergeneric transfer of a beta-lactamase gene between Ps. aeruginosa and E. coli. Nature. 1970 Jun 6;226(5249):952–954. doi: 10.1038/226952a0. [DOI] [PubMed] [Google Scholar]
  17. Traub W. H., Raymond E. A. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Appl Microbiol. 1972 Jan;23(1):4–7. doi: 10.1128/am.23.1.4-7.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tripathy G. S., Chadwick P. The effect of mitomycin C on the pyocine typing patterns of hospital strains of Pseudomonas aeruginosa. Can J Microbiol. 1971 Jul;17(7):829–835. doi: 10.1139/m71-134. [DOI] [PubMed] [Google Scholar]
  19. Yuce K., Van Rooyen C. E. Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection. Can Med Assoc J. 1971 Nov;105(9):919–922. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES